BioArctic AB (publ)
BRCTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $26,133 | $16,155 | $16,085 | $17,882 |
| - Cash | $117 | $948 | $559 | $513 |
| + Debt | $5 | $49 | $51 | $54 |
| Enterprise Value | $26,021 | $15,256 | $15,578 | $17,423 |
| Revenue | $14 | $392 | $1,290 | $101 |
| % Growth | -96.4% | -69.6% | 1,173.9% | – |
| Gross Profit | $13 | $372 | $1,278 | $89 |
| % Margin | 90.8% | 94.8% | 99.1% | 88.3% |
| EBITDA | -$2 | $188 | $1,080 | -$43 |
| % Margin | -11.2% | 47.8% | 83.8% | -42.7% |
| Net Income | -$87 | $97 | $1,021 | -$31 |
| % Margin | -615.2% | 24.6% | 79.2% | -31.1% |
| EPS Diluted | -0.1 | 1.09 | 11.53 | -0.36 |
| % Growth | -109.2% | -90.5% | 3,302.8% | – |
| Operating Cash Flow | -$41 | $1,147 | $12 | -$27 |
| Capital Expenditures | $0 | -$121 | $0 | $0 |
| Free Cash Flow | -$41 | $1,147 | $12 | -$27 |